Lineage-specific hematopoietic growth factors [12]

New England Journal of Medicine

Volumn 355, Issue 5, 2006, Pages 526-527

  Dale, David C ^a   Rosenberg, Philip S ^b   Alter, Blanche P ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; DISEASE PREDISPOSITION; HUMAN; LETTER; MYELODYSPLASIA; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; CHEMICALLY INDUCED DISORDER; NEURAL TUBE DEFECT; NOTE; RISK;

GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEURAL TUBE DEFECTS; NEUTROPENIA; RISK;

EID: 33746762307     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc061587     Document Type: Letter

References (1)

1. Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628-35.